Service providers

AFFILOGIC

Solution provided
Technological/Validation solutions
Supplier indentity
General description
Affilogic is a privately-owned biotech company specialized in discovery and development of a novel class of protein therapeutics called Nanofitins. They are potent antibody-mimetics, exhibiting high affinity and specificity for capture and targeting of biomolecules. Nanofitins also demonstrate many small molecule-like attributes such as a very small size (7 kDa, around 20 times smaller than a monoclonal antibody), an extreme robustness and a better tissue penetration. Deriving from a naturally hyperstable scaffold, Nanofitins are resistant to temperature and pH, stable to proteases, spontaneously refolding… Being under a single protein format, Nanofitins are produced by simple, scaleable, GMP- compliant bacterial fermentation at very attractive costs or by chemical synthesis.
Type of supplier
Biotechnology Company - Therapeutics, Biotechnology R&D Company - Diagnostics / Devices and Diagnostics Services
Sector of activity:
Biotechnology sector
Activity description
Services provided
Affilogic has designed Nanofitins against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (Virus-like Particles, bacteria, whole cells). Nanofitin-based drugs aim at overcoming antibodies limitations and outperforming current targeted therapies by allowing local delivery formulations, single-gene multi-specific molecules and Nanofitin-Drug-Conjugates.
Terms of availability for SMEs
Quality labels and accreditations
Region
Region of Pays de la Loire, FR
Contact information
Name
Olivier KITTEN
Function
Founder & CEO
Phone number
Website
Address
21 rue La Noue Bras de Fer
44200 Nantes
France
Partner contact information
Company name
Atlanpole Biotherapies
Phone number
+33 2 40 25 13 13
Address
95 route de Gachet
44300 Nantes

Upcoming events

09
Oct
09 Oct 2018 to 11 Oct 2018MadridSpain

From the 9th to the 11th of October, the pharmaceutical world will gather in Madrid for CPhI Worldwide 2018. In the course of three days IFEMA - Feria de Madrid will host more than 2500 companies exhibiting innovative products and technology from verified manufacturers. Some 45,000 professional visitors will attend the upcoming CPhI in Spain’s capital.

Agenda

Mo Tu We Th Fr Sa Su
 
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31